Refine your search
Collections
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Sivakumari, K.
- Molecular Docking Study of Bark-derived Components of Cinnamomum Cassia on Aldose Reductase
Abstract Views :457 |
PDF Views:193
Authors
Affiliations
1 Dept. of Zoology, Presidency College, Chennai–600005, IN
2 Dept. of Biotechnology, Sri Venkateswara College of Engineering, Chennai-602105, IN
1 Dept. of Zoology, Presidency College, Chennai–600005, IN
2 Dept. of Biotechnology, Sri Venkateswara College of Engineering, Chennai-602105, IN
Source
Indian Journal of Science and Technology, Vol 3, No 10 (2010), Pagination: 1081-1088Abstract
Aldose reductase (AR) is an enzyme associated with retinopathy of both type 1 and type 2 diabetic patients. AR is inhibited by giving chemical drugs to prevent diabetic retinopathy, but is associated with deleterious side effects. Compounds isolated from plants are safer than chemical drugs and have a lot of potential. In the present study, three components viz., cinnamaldehyde, cinnamic acid and cinnamyl alcohol derived from the bark of Cinnamomum cassia were used to evaluate their efficiency in inhibiting AR activity. For this, the AR protein structure database was downloaded from PDB and its pictorial database was downloaded from PDBsum. Structural visualization of AR was done by RasMol. Using Q-SiteFinder, prediction of ligand binding site was done. The three dimensional structures of inhibitors viz., cinnamaldehyde, cinnamic acid and cinnamyl alcohol were downloaded from ChemSketch. Docking studies were carried out using ArgusLab software. Docking studies of cinnamaldehyde, cinnamic acid and cinnamyl alcohol against AR was undertaken to gain insight into the binding mode of the investigated compounds at the active site of AR. All compounds were found to be active against AR as indicated by docking results; the best being cinnamaldehyde. Results suggest that cinnamaldehyde, cinnamic acid and cinnamyl alcohol should be evaluated further for therapeutic use in combination with other diabetic drugs. Further, this may be confirmed by drug trials in animal models to find out the optimum dose and its efficiency in inhibiting AR activity to treat diabetic related complicationsKeywords
Diabetes, Aldose Reductase, Cinnamon, Molecular DockingFull Text
References
- Alcolado J (1998) Genetics of diabetic complications. Lancet. 351, 230-231.
- Bhatnagar A and Srivastava SK (1992) Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem. Med. Metab. Biol. 48, 91-121.
- Bowles BL and Miller AJ (1993) Antibotulinal properties of selected aromatic and aliphatic aldehydes. J. Food Prot. 56, 788-794.
- Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature. 414, 813-820.
- DCCTRG (The diabetes control and complications trial research group) (1993) The effect of intensive insulin treatment of diabetes on the development and progression of long term complications in insulin dependent Diabetes mellitus. N. Engl. J. Med. 329, 977- 986.
- FAO/WHO (1968) Specifications for the identity and purity of food additives and their toxicological evaluation: some flavoring substances and non-nutritive sweetening agents. 11th report of the joint FAO/WHO expert committee on food additives, FAO nutrition meetings report series no. 44, Wld. Hlth Org. Techn. Rep. Ser. No. 383.
- Graham A, Brown L, Hedge PJ, Gammack AJ and Markham AF (1991a) Structure of the human aldose reductase gene. J. Biol. Chem. 266, 6872-6877.
- Graham A, Heath P, Morten JEN and Markham AF (1991b) The human aldose reductase gene maps to chromosome region 7q35. Hum. Genet. 86, 509-514.
- Hamada Y, Kitoh R and Raskin P (1991) Increased erythrocyte aldose reductase activity in type 1 diabetic patients. Diabetic Med. 8, 226-231.
- Hamada Y, Kitoh R and Raskin P (1993) Association of erythrocyte aldose reductase activity with diabetic complications in type 1 Diabetes mellitus. Diabetic Med. 10, 33-38.
- Haraguchi H, Ohmi I, Sakai S and Fukuda A (1996a) Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes. J. Nat. Prod. 59, 443-445.
- Haraguchi H, Ohmi I, Masuda H, Tamura Y, Mizutani K, Tanka O and Chou WH (1996b) Inhibition of aldose reductase by dihydroflavonols in Engelhardtia chrysolepis and effects on other enzymes. Experientia 52, 564-567.
- Haraguchi H, Kanada M, Fukuda A, Naruse K, Okamura N and Yagi A (1998) An inhibitor of aldose reductase and sorbitol accumulation from Anthocepharus chinensis. Planta Medica 64, 68-69.
- Kador PF, Robison WG and
- Kinoshita JH (1985) The pharmacology of aldose reductase inhibitors. Ann. Rev. Pharmacol. Toxicol. 25, 691-714.
- Kim MK, Kim SY and Lee HS (2001) Rat lens aldose reductase inhibitory activities of oriental medicinal plants. Agric. Chem. Biotechnol. 45, 84-88.
- Kim MK, Lee SE and Lee HS (2000) Growth-inhibiting effects of Brazilian and oriental medicinal plants on human intestinal bacteria. Agric. Chem. Biotechnol. 43, 54-58.
- Lee AY and Chung SS (1999) Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1, 23-30.
- Lee HS and Ahn YJ (1998) Growth-inhibiting effects of Cinnamomum cassia bark-derived materials on human intestinal bacteria. J. Agric. Food. Chem. 46, 8-12.
- Lee HS (2002a) Inhibitory activity of Cinnamomum cassia bark-derived component against rat lens aldose reductase. J. Pharm. Pharmaceut. Sci. 5(3), 226-230.
- Lee YS, Lee S, Lee HS, Kim BK, Ohuchi K and Shin KH (2005) Inhibitory effects of isorhamnetin-3-Q-beta-Dglucoside from Salicornia herbacea on rat lens aldose reductase and sorbitol accumulation in streptozotocininduced diabetic rat tissues.Biol.Pharm.Bull.28(5),916-918
- Matsuda H, Murakami T, Yashiro K, Yamahara J and Yoshikawa M (1999) Antidiabetic principles of natural medicines. Aldose reductase and glucosidase inhibitors from the ischolar_mains of Salacia oblonga Wall. (Celastraceae): Structure of a new friedelane-type triterpene, kotalagenin 16-acetate. Chem. Pharm. Bull. 47, 1725-1729.
- Moleyar V and Narasimham P (1992) Antibacterial activity of essential oil components. Int. J. Food Microbiol. 16, 337-342.
- Morimoto S, Nonaka G and Nishioka I (1986) Tannins and related compounds XXXVIII. Isolation and characterization of flavan-3-ol glucosides and procyanidin oligomers from cassia bark (Cinnamomum cassia Blume). Chem. Pharm. Bull. 34, 633-642.
- Nagata M, Hohman TC, Nishimura C, Drea CM, Oliver C and Robison WG Jr (1989) Polyol and vacuole formation in cultured canine lens epithelial cells. Exp. Eye Res. 48, 667-677.
- Nakamura J, Kasuya Y, Hamada Y, Nakashima E, Naruse K, Yasuda Y, Kato K and Hotta N (2001) Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity. Diabetologia 44(4), 480-487.
- Namba T (1986) Colored Illustrations of Wakan-Yaku In: The Crude Drugs in Japan, China and the Neighbouring Countries. Hoikusha Publishing, Osaka, Japan.
- Nishimura C, Saito T, Ito T, Omori Y and Tamimoto T (1994) High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia 37, 328-330.
- Opdyke DLJ (1978) Fragrance raw materials monographs. Food Cosmet. Toxicol. 16, 687-689.
- Pyke DA and Tattersall RB (1973) Diabetic retinopathy in identical twins. Diabetes 22, 613-618.
- Radha V, Rema M and Mohan V (2002) Genes and diabetic retinopathy. Indian J. Ophthalmol. 50(1), 5-11.
- Rao AA, Thota H, Gumpeny RS, Akula A, Changalasetty SB, Challa SR, Ravavarapu T, Akula SP, Divakar CH, Srinivas K and Das UN (2008) Bioinformatics analysis of diabetic retinopathy using functional protein sequences. Med. Hypotheses 70(1), 148-155.
- Raskin P and Rosenstock J (1987) Aldose reductase inhibitors and diabetic complications. Am. J. Med. 83, 298- 306.
- Sheetz MJ and King GL (2002) Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288, 2579-2588.
- Shimizu M, Horie S, Arisawa M, Hayashi T, Suzuki S, Yoshizaki M, Kawasaki M, Terashima S, Tsuji H, Wada S, Ueno H, Morita N, Berganza LH, Ferro E and Basualdo I (1987) Chemical and pharmaceutical studies on medicinal plants in Paraguay. I. Isolation and identification of lens aldose reductase inhibitor from ‘Tapecue’ Acanthospermum australe O.K. Chem. Pharm. Bull. 35, 1234-1237.
- Tomlinson DR, Stevens EJ and Diemel LT (1994) Aldose reductase inhibitors and their potential for the treatment of diabetic complications.Trends Pharmacol.Sci. 15,293-297.
- Trueblood N and Ramasamy R (1998) Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. Am. J. Physiol. 275, H75-H83.
- Tsukushi S, Katsuzaki T, Aoyama I, Takayama F, Miyazaki T, Shimokata K and Niwa T (1999) Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: Role of the polyol pathway. Kidney Int. 55, 1970- 1976.
- Williamson J, Kilo C and Tilton RG (1992) Mechanism of glucose- and diabetes-induced vascular dysfunction. In: Hyperglycemia, Diabetes, and Vascular Disease (eds. Ruderman N, Williamson J and Brownlee M) pp. 107-132. American Physiological Society, New York, USA.
- Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C and Tilton RG (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42(6), 801-813.
- Yabe-Nishimura C (1998) Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacol. Rev. 50, 21-33.
- Yoshikawa M, Shimada H, Norihisa N, Li Y, Toguchida I, Yamahara J and Matsuda H (1998) Antidiabetic principles of natural medicines. II. Aldose reductase and aglucosidase inhibitors from Brazilian natural medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): Structures of myrciacitrins I and II and Myrciaphenones A and B. Chem. Pharm. Bull. 46, 113-119.